Addressing the challenges posed by viruses to the medical community and society will be an ongoing feature of Virus & Life, a journal launched recently at the 5th International Conference on Antiviral Research in Vancouver, Canada. V&L is unique in being the only international journal to cover all aspects of clinical virology for specialists and clinicians working in the virology field, as well as those who treat patients infected with viral diseases, according to its publisher, The Medicine Group.
Clinical and basic research in virology is in a state of intense development which results in a time lag before new findings are incorporated into clinical practice, says the journal's medical editor, Nicholas Bell. "Virus & Life aims to shorten this gap by disseminating new information in a comprehensive and useful form to clinicians," he told the Marketletter.
All V&L articles are commissioned by an independent editorial board and written by international virology specialists. Funding for the quarterly publication has been provided by an educational grant from SmithKline Beecham. As a company at the forefront of antiviral research, SB says the investment is part of its commitment to continuing medical information and post-graduate research in this rapidly advancing field.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze